Synta Pharma (SNTA) Misses Q3 Views; Loss Wider by 3c
Tweet Send to a FriendGet Alerts SNTA Hot Sheet
Price: $3.95 -1.25%
Revenue Growth %: -100.0%
Financial Fact:
Research and development: 16.38M
Today's EPS Names:
ATU, CRWS, CLC, More
Revenue Growth %: -100.0%
Financial Fact:
Research and development: 16.38M
Today's EPS Names:
ATU, CRWS, CLC, More
Trade SNTA Now!
Synta Pharmaceuticals Corp. (Nasdaq: SNTA) reports Q3 loss of $0.25, versus the consensus of ($0.22). Revenue for the quarter came in at $3.38 million, compared to the consensus of $4.11 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Synta Pharmaceuticals (SNTA) CEO Buys Another 10K Shares
- Crown Crafts, Inc. (CRWS) Posts Flat Q4 EPS of 19c
- China Cord Blood Corp. (CO) Tops Q4 EPS by 3c
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
